Navigation Links
Panitch Schwarze Adds Biotechnology and Life Science Experts to IP team

Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Travis W. Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany G. Small, Ph.D., has joined the firm as a patent agent.

Bliss is an experienced patent attorney and will be a partner in the firm’s biotechnology and life science practice group. He has significant experience with domestic and foreign patent applications and trademark procurement. His practice also involves IP counseling, providing a comprehensive view of the IP landscape to help clients to determine strategy. His experience in life sciences includes assisting companies in the biotechnology and pharmaceutical industries, as well in the agriculture, horticulture, cannabis, and hemp industries. Bliss is a thought leader in the area of procuring and monetizing IP protections for plant-based inventions, including novel cannabis and hemp varieties and products. He also is ranked in the Nationwide Band 1 for cannabis law by Chambers USA.

Bliss’s IP litigation experience includes litigating patent and trademark infringement disputes, trade secret disputes, licensing disputes and inventorship disputes in both state and federal courts. He has defended both large and small companies against charges of trade secret misappropriation and patent infringement. Bliss has litigated numerous disputes, including patent interference and inter partes review proceedings, before the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB).

Bliss earned his bachelor’s degree in animal science with a concentration in agricultural biotechnology and his doctoral degree in animal science focusing on molecular genetics, immunology, and biotechnology from the University of Delaware. He received his law degree, summa cum laude, from Widener University. Prior to joining Panitch Schwarze, he served as chair of the IP Biotechnology & Life Sciences practice group at Buchanan Ingersoll & Rooney P.C.

Small is an experienced patent agent with expertise in life science fields. As a new member of the firm’s life sciences practice group, Small provides technical support and scientific expertise in the pharmaceutical and biotechnical arts, as well as in the area of IP protections for novel plant varieties. She assists clients in the preparation, filing and prosecution of domestic and foreign patent applications, as well as conducting searches and reviews for due diligence, patentability and freedom to operate analyses. She is involved in FDA Orange Book submissions and Patent Term Extension Applications, and has also litigated patent interferences and inter partes review proceedings before the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB).

Small earned a bachelor’s degree in biology and theology from The Franciscan University of Steubenville and her doctoral degree in cellular and microbial biology from The Catholic University of America, where she was recognized with the Roland M. Nardone Award for Excellence in Teaching Assistance. Prior to joining Panitch Schwarze, Small worked as a patent agent at another law firm in the Philadelphia area.

“We are pleased to welcome Travis and Stephany to our life sciences team,” said managing partner Martin Belisario “Their experience in sciences, including novel plant varieties, complements our team members’ experience and skills to expand the firm’s ability to support our clients’ growing needs in the pharmaceutical and biotechnology arena.”

To learn more, visit the firm’s website.

About Panitch Schwarze Belisario & Nadel LLP – Panitch Schwarze Belisario & Nadel LLP is a boutique intellectual property law firm with offices in Philadelphia and Wilmington, Delaware. The firm’s IP law practitioners provide strategic litigation, licensing and counseling service relating to patents, trademarks, copyrights and trade secrets, domain names and internet issues domestically and internationally. The firm’s long-standing relationships with a network of associates worldwide enable its attorneys and advisors to provide clients with global intellectual property advice and protection.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Panitch Schwarze Belisario & Nadel LLP Welcomes Gunes Bender as Patent Agent
2. Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award
3. 2013 AAPS National Biotechnology Conference returns to San Diego
4. AAPS announces 2013 National Biotechnology Conference award winners
5. Frontiers launches new open-access journal in Bioengineering and Biotechnology
6. Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
7. Unique industry-academia networks in industrial biotechnology and bioenergy launched
8. New patenting guidelines are needed for biotechnology
9. Engineered E. coli produces high levels of D-ribose as described in Industrial Biotechnology journal
10. AAPS announces 2014 National Biotechnology Conference award winners
11. Space Station top results for biotechnology, health and education announced
Post Your Comments:
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate ... reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators ...
(Date:7/10/2020)... ... , ... Today CJ BIO announced the first in a series of Food ... phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range ... 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced today ... Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding ... of academic research centers in the United States and Europe with expertise in ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed that ... FDA compliance consulting has been named on its annual Inc. 5000 list, the ... unique look at the most successful companies within the American economy’s most dynamic ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
Breaking Biology Technology: